Ipamorelin/CJC-1295 Blend 10mg v2

Ipamorelin/CJC-1295 Blend 10mg v2 — Research Overview

CJC-1295 No DAC 5mg + Ipamorelin 5mg dual-pathway blend. 99.0% purity. GHRH + GHSR co-activation without cortisol or prolactin elevation; suitable for selective GH pulse research.

Related Products

Stack

98.7%

Cagri-Sema Blend 10mg

Pre-formulated Cagrilintide 5mg + Semaglutide 10mg blend. 98.7% purity. CagriSema Phase 2: −15.6% weight loss at 32 weeks; dual amylin + GLP-1 pathway co-activation in single vial.

$179.99

Order

Stack

98.5%

Cagri-Reta 5mg

Cagrilintide + Retatrutide research blend, 5mg total. 98.5% purity. Combines amylin analogue satiety signalling with triple GLP-1/GIP/glucagon agonism; starter-scale co-agonist protocol vial.

$129.99

Order

98.5%

Cagri-Reta 10mg

Cagrilintide + Retatrutide research blend, 10mg total. 98.5% purity. Amylin + triple-receptor agonism co-administration supply; supports two-week extended-dose comparative studies.

$189.99

Order

Stack

98.5%

Reta-Cagri 5mg/5mg

Retatrutide 5mg + Cagrilintide 5mg equimolar pre-formulated stack. 98.5% purity. Triple GLP co-agonism plus central amylin satiety — distinct dual-pathway mechanistic research format.

$149.99

Order